After seconds your should be redirected to new site.

Primus inter pares

The Second Plenary Session of the Project 5-100 Seminar-Conference

The first day of the Seminar-Conference of Project 5-100 featured two plenary sessions on the best practices by Sechenov First MGMU. At the first meeting the Rector, Petr Glybochko delivered the keynote address scrutinizing his state-of-the-art model of continuous medical education "School-University-Clinic", embedding information technologies in the collegiate management processes and polylingual education, which literally stole the show. The second sitting dedicated to some topical biomedical points, became a real hit for those who are engaged in scientific research and medical practices at the crossroads of ideas and technologies fusing biochemistry, immunology, cell and molecular biology, regenerative medicine.
The University had a lot to offer for the discussion at the session. In particular, the studies integrating the molecular and genetic basis of the etiology and pathogenesis of socially significant diseases, and also new diagnosis and therapy techniques employing bioengineering technologies were received quite favourably by the audience.
Presentations were performed by Director of the Institute of Molecular Medicine Andrey Zamyatin, Deputy Director of the Research Institute of Uronefrology and Reproductive Health Denis Butnaru, and Prof. Alexander Nosyrev of Analytical Toxicology, Pharmaceutical Chemistry and Pharmacognosy Department.
Andrei Zamyatin presented his new developments at the interface of biology and medicine, including molecular diagnostics, drug design and regenerative medicine – the cycle of projects, which are being evolved in cooperation with other departments of the University. The key achievements of the Research Institute of Molecular Medicine comprise cancer and hereditary diseases detection methodologies, tuberculous vaccine (currently being tested by the WHO), antitumoral drugs and a number of other medicines. 
The Research Institute of Uronefrology is the biomedicine research frontline. Denis Butnaru recounted the intercollegiate cooperation with the US Wake Forest University in the field of cell therapy of urological diseases, tissue-engineering (hybrid matrices) technologies, and also mentioned those trendy 3-d bioprinting innovations. “This is much promising to print organs and tissues from special gel saturated with cells or spheroids using the approach proposed by Prof. Vladimir Mironov”, believes Denis Butnaru. Among other challenging developments, the 3-d laser chitosan-based stereolithography and studies on hybridoma that generates monoclonal antibodies used for oncology cases. Together with the chemical lab of Lomonosov Moscow State University the FMSMU researchers fall upon non-invasive cancer diagnostic methodology and this is only a part of extensive collaboration. Denis Butnaru noted that biomedicine studies require application of multidisciplinary approach and synergy of researchers. 
Personalized, regenerative and molecular – each of these medicine branches got a new development impetus thanks to the First MSMU best practices.